Acadian Asset Management’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-45,366
Closed -$87K 1920
2024
Q1
$87K Buy
45,366
+24,704
+120% +$47.4K ﹤0.01% 1312
2023
Q4
$29K Buy
+20,662
New +$29K ﹤0.01% 1542
2023
Q1
Sell
-26,419
Closed -$57K 2006
2022
Q4
$57K Buy
+26,419
New +$57K ﹤0.01% 1558
2022
Q3
Sell
-19,963
Closed -$57K 1882
2022
Q2
$57K Buy
+19,963
New +$57K ﹤0.01% 1477
2021
Q3
Sell
-42,724
Closed -$208K 2061
2021
Q2
$208K Sell
42,724
-59,973
-58% -$292K ﹤0.01% 1432
2021
Q1
$457K Buy
102,697
+19,645
+24% +$87.4K ﹤0.01% 1231
2020
Q4
$322K Hold
83,052
﹤0.01% 1376
2020
Q3
$269K Buy
83,052
+15,088
+22% +$48.9K ﹤0.01% 1350
2020
Q2
$302K Buy
+67,964
New +$302K ﹤0.01% 1354
2019
Q4
Sell
-30,576
Closed -$107K 2092
2019
Q3
$107K Buy
+30,576
New +$107K ﹤0.01% 1473
2019
Q2
Sell
-8,704
Closed -$67K 2069
2019
Q1
$67K Hold
8,704
﹤0.01% 1611
2018
Q4
$60K Hold
8,704
﹤0.01% 1389
2018
Q3
$99K Buy
8,704
+4,565
+110% +$51.9K ﹤0.01% 1207
2018
Q2
$52K Buy
4,139
+1,746
+73% +$21.9K ﹤0.01% 1379
2018
Q1
$88K Buy
2,393
+1,972
+468% +$72.5K ﹤0.01% 1250
2017
Q4
$21K Buy
+421
New +$21K ﹤0.01% 1361
2017
Q3
Sell
-452
Closed -$21K 1552
2017
Q2
$21K Buy
452
+86
+23% +$4K ﹤0.01% 1253
2017
Q1
$18K Hold
366
﹤0.01% 1389
2016
Q4
$11K Hold
366
﹤0.01% 1426
2016
Q3
$16K Buy
366
+262
+252% +$11.5K ﹤0.01% 1177
2016
Q2
$4K Buy
+104
New +$4K ﹤0.01% 1325
2015
Q4
Sell
-12
Closed -$2K 1524
2015
Q3
$2K Buy
+12
New +$2K ﹤0.01% 1262